WASHINGTON (AP) — Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer’s drug, a key step toward opening insurance coverage to U.S. seniors with early stages of the brain-robbing disease. The drug, Leqembi, received conditional approval from the Food and Drug Administration in January based…Read More
Alzheimers drug gets FDA panels backing setting the stage for broader use Fox 11 Tri Cities Fox 41 Yakima
